JAMES P FOGARTY

CIK 1224818 · President and CEO · last filed 2025-09-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.27M

Companies

5

Total Filings

32

Lifetime Open-Market Net

$1.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DRI Director 26,548 $211.47 $5.61M $639.5K 22 2025-09-19
ASRT Director 75,546 $23.48 $1.77M $0 1 2019-05-09
Assertio Therapeutics, Inc (DEPO) Delisted Director $0 3 2018-05-10
RGS Director 25,890 $27.21 $704.5K $0 4 2014-10-30
CHRS President and CEO 125,000 $1.40 $175.0K $468.6K 2 2010-06-25

Recent Filings · Page 2 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-09-20 DRI Grant (A) $0 EDGAR
2019-05-09 ASRT Mixed +70,834 $0 EDGAR
2018-09-21 DRI Mixed +1,565 $0 EDGAR
2018-05-10 Assertio Therapeutics, Inc (DEPO) Delisted Grant (A) $0 EDGAR
2017-09-25 DRI Mixed +1,979 $0 EDGAR
2017-08-16 Assertio Therapeutics, Inc (DEPO) Delisted Grant (A) $0 EDGAR
2016-10-19 Assertio Therapeutics, Inc (DEPO) Delisted Grant (A) $0 EDGAR
2016-10-03 DRI Grant (A) $0 EDGAR
2016-07-11 DRI Buy (P) +3,000 $185.1K EDGAR
2015-09-29 DRI Buy (P) +2,900 $204.4K EDGAR
Showing 1120 of 32
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.